drugset / Trial / NCT07067099
Neutralizing Interferon Type 1 in Hidradenitis Suppurativa
Phase 1
Not yet recruiting
6 enrolled
Centre Hospitalier Universitaire de Besancon
Etablissement Français du Sang · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety and type 1 Interferon (IFN) neutralization in patients with refractory severe Hidradenitis Suppurativa (Hurley stage III) after transfusion of plasma containing high titer anti-IFN-1 autoantibodies.
Timeline
- Start
- 2025-09
- Primary completion
- 2026-06
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plasma with neutralizing autoantibodies to Type I Interferons | Protein / enzyme biologic | 1 unknown | Other |